• Small Molecules
    • Large Molecules
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers


Choose from a variety of resources to get a better understanding of Syngene’s point of view, expertise or approach to drug discovery, development and manufacturing to ensure client success.

Building resilience in Supply Chain Management - the Syngene way

Syngene has a well-defined system that delivers across all aspects of Supply Chain Management, ranging from planning and inventory to sourcing, procurement, logistics, performance, safety, and compliance.

Comprehensive solutions for clinical development of generic drugs

Synene has developed more than 100 assays for conducting BA/BE studies across small and large molecules.

Audit Syngene Virtually

Syngene is using virtual audits to enable clients/regulators experience its capability and infrastructure, without physically visiting the site.

ICH Stability Services

One of the largest Stability facilities in Asia, Syngene supports both small and large molecules from early development to CMC 

Targeted Protein Degradation_PROTACs

Syngene has considerable experience solving synthetic chemistry and purification challenges with PROTACS.

Syngene Biologics Developement & Manufacturing

Syngene offers Biologics development and Biomanufacturing solutions in both mammalian and microbial systems.

Syngene Chemical Development

Syngene  has full value-chain Process Research and Development (PRD) capabilities for NCEs and advanced intermediates.

Syngene Clinical Development

Syngene supports early-phase to late-phase clinical trials required for drug development programs across a wide range of therapeutic areas.

Syngene Commercial Manufacturing

Syngene supports manufacturing of regulatory starting materials, APIs, HPAPI, NCEs and novel advanced intermediates

Syngene Formulation Development

Syngene supports both development  and manufacturing of Drug Products from early to late stage.

This Website uses Cookies

We use cookies to improve your experience on our site and show you information relevant to your requirements.

To find out more, read our Privacy Policy and Cookies Policy.

To download, Please share your details

To download, Please share your details